Thomas Doerr

Subcutaneous Epcoritamab in Relapsed or Refractory Large B-Cell Lymphoma: Pivotal Results from the Phase 2 EPCORE NHL-1 Trial

Introduction:More tolerable, readily available treatment options are needed for patients with relapsed or refractory (R/R) large B-cell lymphoma (LBCL) to induce deep, durable responses. ...

Michael Roost Clausen ;

Mariana Sacchi ;

Catherine Thieblemont ;

Martin Hutchings ;

Tycel Phillips ;

Pieternella Lugtenburg ;

Herve Ghesquieres ;

Chan Y. Cheah ;

Young R. Do ;

Tatyana Feldman ;

Robin Gasiorowski ;

Wojciech Jurczak ;

Tae Min Kim ;

David J. Lewis ;

Mariolein van der Poe ;

Michelle L. Poon ;

Thomas Doerr ;

Nurgul Kilavuz ;

David Cunningham ;

Menghui Chen ;

11/04/2022

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Thomas Doerr

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products